PR Newswire JERSEY CITY, N.J., March 12, 2025 JERSEY CITY, N.J., March 12, 2025 /PRNewswire/ -- Celltrion today announced the U.S. launch of STEQEYMA® (ustekinumab-stba), a biosimilar to STELARA® (ustekinumab), following approval by the U.S. ...
PR Newswire HONG KONG, March 11, 2025 HONG KONG, March 11, 2025 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX:1672, "Ascletis") announces encouraging pharmacokinetic and weight loss data from its ASC47 Phase Ib single subcutaneous injection ...
PR Newswire PARAMUS, N.J., March 10, 2025 PARAMUS, N.J., March 10, 2025 /PRNewswire/ -- NS Pharma, Inc. (NS Pharma), a subsidiary of Nippon Shinyaku Co., Ltd. (Nippon Shinyaku), announced today that acceptance has been received by Capricor ...
PR Newswire VALBY, Denmark, March 10, 2025 VALBY, Denmark, March 10, 2025 /PRNewswire/ -- The Ministry of Health, Labor, and Welfare (MHLW) in Japan has granted Orphan Drug Designation (ODD) to Lundbeck's investigational drug, amlenetug, a ...
PR Newswire HONG KONG, March 7, 2025 HONG KONG, March 7, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is excited to announce that the groundbreaking results of the Phase III clinical study (HARMONi-2/AK112-303) of ...
TAIPEI, Taiwan, March 07, 2025 (GLOBE NEWSWIRE) -- Amaran Biotechnology Inc., a subsidiary of OBI Pharma specializing in Contract Development and Manufacturing Organization (CDMO) services for next-generation pharmaceuticals, announced today ...
PR Newswire SAN ANTONIO, March 4, 2025 Petco Love Aims to Distribute 1 Million More Free Vaccines Through Vaccinated and Loved Initiative to Protect Pets and Strengthen Communities SAN ANTONIO, March 4, 2025 /PRNewswire/ -- Petco Love, a ...
PR Newswire JERSEY CITY, N.J., March 3, 2025 JERSEY CITY, N.J., March 3, 2025 /PRNewswire/ -- Celltrion today announced that the U.S. Food and Drug Administration (FDA) has approved STOBOCLO® (CT-P41, denosumab-bmwo) and OSENVELT® (CT-P41, ...
PR Newswire MELBOURNE, Australia, March 3, 2025 Highlights: MELBOURNE, Australia, March 3, 2025 /PRNewswire/ -- Avecho Biotechnology Limited (ASX: AVE) ("Avecho" or the "Company") today announced it has signed an exclusive ten-year ...
PR Newswire THOUSAND OAKS, Calif., March 3, 2025 LTG-001 demonstrated favorable safety and tolerability profile with predictable pharmacokinetics in Phase 1 trial Fast Track designation will facilitate development and expedited ...
Lecanemab use is higher among white, male, urban, and wealthier patients despite broad Medicare coverage.
New antifungal nanotechnology uses targeted liposomes to boost drug delivery and fight Candida infections.
Real-world evidence shows long-term use of oral and inhaled steroids increases the risk of adrenal insufficiency, highlighting the need for proper treatment alternatives.
Legalizing and increased consumption of cannabis has led to increased cases of people visiting hospitals, many due to anxiety, psychosis, and other mental health disorders.
Glucagon-like peptide-1 receptor agonists improve cardiovascular outcomes and reduce mortality in patients with type 2 diabetes.
Subscribe to our Free Newsletters!
Medindia's policies are aligned with the United Nations Sustainable Development Goals (SDGs) - SDG 3, SDG 4, SDG 5, SDG 6 , SDG 10 & SDG 12.
Disclaimer - All information and content on this site are provided for informational and educational purposes only. They should NOT be used for the diagnosis or treatment of any health-related condition or disease. Always consult a qualified healthcare professional for medical advice, diagnosis, or treatment. Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2025
Careers